Contribute Try STAT+ Today

WASHINGTON — The Trump administration is being flooded with opposition to its plan for allowing states to import cheaper drugs from Canada.

In December, the administration released a draft plan that would allow states to partner with drug wholesalers to import drugs from Canada. A number of states, including Florida, Colorado, and Maine, are already champing at the bit to start importing, but the Trump administration will have to overcome monumental opposition from nearly every corner of the drug supply chain if it wants to finalize the pathway that will make that possible.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.